Dr. Reddy's Laboratories

Bortezomib

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Dr. Reddy's Laboratories

Bortezomib HCPCS:

J9046

HCPCS Code Descriptor:

Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg

Category:

J Code

Bortezomib NDCs:

43598-0865-60

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Bortezomib CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

43598-0865-60

About Bortezomib:

Bortezomib is an Oncology drug manufactured by Dr. Reddy's Laboratories and administered via the Intravenous route of administration. The J Code: J9046 is aligned to the drug Bortezomib.

ACCESS PRICING AND MORE BY REGISTERING

J9046 Added Date:

January 1, 2023

J9046 Effective Date:

January 1, 2023

J9046 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bortezomib billing and coding information.
Bortezomib patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
Bortezomib prescribing information can be found at the link below:
Information regarding Bortezomib’s side effects can be found at MedlinePlus